...
首页> 外文期刊>Bioanalysis >Detection limit enhancement of antiarrhythmic drugs in human plasma using capillary electrophoresis with dispersive liquid-liquid microextraction and field-amplified sample stacking method
【24h】

Detection limit enhancement of antiarrhythmic drugs in human plasma using capillary electrophoresis with dispersive liquid-liquid microextraction and field-amplified sample stacking method

机译:毛细管电泳-分散液-液微萃取-场放大样品叠加法提高人血浆抗心律失常药物的检测限

获取原文
获取原文并翻译 | 示例
           

摘要

Background: A new capillary zone electrophoresis (CZE) with ultraviolet detection method has been developed and validated for the analysis of four antiarrhythmic drugs in human plasma samples. Methods: In this study, a dispersive liquid-liquid microextraction (DLLME) coupled with field-amplified sample stacking (FASS) was employed for biological samples clean-up and sensitivity enhancement in CZE. Results: Under optimum DLLME-FASS-CZE conditions, enhancement factors were in the range of 157-314. The method was validated over the concentration range of 20-800 ng/ml in human plasma. Inter- and intra-day precision and the accuracy were less than 20%; the detection limits ranged from 2.5 to 4.7 ng/ml. Furthermore, the validated method was successfully applied to the detection of studied drugs in patients' plasma samples.
机译:背景:已开发出一种新型的紫外线检测毛细管区带电泳(CZE),并已用于分析人体血浆样品中的四种抗心律不齐药物。方法:在这项研究中,采用分散液-液微萃取(DLLME)结合现场放大样品堆叠(FASS)进行CZE中生物样品的净化和灵敏度提高。结果:在最佳DLLME-FASS-CZE条件下,增强因子在157-314范围内。该方法在人血浆中20-800 ng / ml的浓度范围内得到验证。日间和日内精度和精度均小于20%;检出限为2.5至4.7 ng / ml。此外,已验证的方法已成功地用于检测患者血浆样品中研究药物的检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号